A Multifaceted Approach

Close this search box.

Get Your Life Back From

Long Covid Covid Post Covid

Clinically researched nutraceuticals designed to enhance overall health by revitalizing essential organs. Supports individuals experiencing active COVID and those dealing with post/long-term COVID symptoms.

Our Treatment Focus

Detoxification of Spikeopathy

Our strategy for the detoxification of “Spikeopathy” involves a 4-step process.

  1. The first step is to help restore autophagy processes, which are the body’s natural way of cleaning out damaged cells and regenerating new ones. 
  2. The second step aids in liberating the virus and spike Protein by selectively targeting infected or transfected cells. 
  3. The third step facilitates the sequestration of free-floating spike Protein and virus, effectively capturing and containing them. 
  4. Finally, the fourth step is focused on preventing reinfection by blocking the receptors on host cells, which the virus and spike Protein use to gain entry. 

This comprehensive approach aims to remove the spike Protein from the body safely while also enhancing the immune system’s ability to prevent further infections.

The Specific Pathways targeted by Vedicinals®9

Vedicinals®9 targets specific pathways through its composition of nine bioactive molecules, each chosen for their ability to interact with and modulate various biological processes relevant to combating Long Covid, COVID-19 and its associated conditions. Here’s a detailed look at how Vedicinals®9 targets specific pathways:

  1. Anti-Viral Action: Vedicinals®9 employs a multi-targeted approach to inhibit the virus. It attacks the virus on 8 different structural Proteins, including the 3cL-Pro/M-Pro virus protease. This protease has shown little to no mutations since 2004, making it a stable target for antiviral action. By targeting multiple structural Proteins of the virus, Vedicinals®9 aims to prevent the virus from entering human cells and replicating.
    Media Link: https://www.biospace.com/article/german-indian-biotech-company-s-nutraceutical-compound-shows-promising-use-an-adjuvant-to-treat-covid-19-in-randomized-clinical-trial/
    Media Link: https://www.hindustantimes.com/brand-post/healthshield-against-post-covid-the-3rd-wave-of-the-pandemic-101626788907633.html

  2. Anti-Inflammatory and Host Resilience: The compound defends against the virus by blocking human receptors and modulating enzymes, creating unfavorable conditions for virus entry and multiplication within human cells. This mechanism not only helps in reducing inflammation but also enhances the host’s resilience against the virus.
    Media Link: https://www.hindustantimes.com/brand-post/healthshield-against-post-covid-the-3rd-wave-of-the-pandemic-101626788907633.html

  3. Organ Protection: Vedicinals®9 contains molecules with organ-protective properties. These bioactive molecules are specifically chosen to protect, repair, and rejuvenate vital organs that may be attacked or damaged by the virus or by the body’s inflammatory response. This organ-protective action is crucial for mitigating the long-term health complications associated with COVID-19.

  4. Cardioprotection: Beyond its antiviral and anti-inflammatory effects, Vedicinals®9 has been shown to provide significant protection to the cardiovascular system. This includes protecting heart blood vessels, which is particularly important given the increased risk of cardiovascular complications in COVID-19 patients.
    Media Link: https://www.biospace.com/article/german-indian-biotech-company-s-nutraceutical-compound-shows-promising-use-an-adjuvant-to-treat-covid-19-in-randomized-clinical-trial/

The nine bioactive molecules in Vedicinals®9 are Baicalin, Hesperidin, Luteolin, Quercetin, Rutin, Glycyrrhizin, Epigallocatechin gallate, Curcumin, and Piperine. These molecules were selected based on silico studies, meta-analysis of past published studies, and their ability to correct or stop various human host cellular pathways disruptions caused by the SARS-CoV-2 coronavirus.

Our multifaceted approach, targeting both the virus and the host’s response, positions Vedicinals®9 as a promising adjuvant therapy for COVID-19, with the potential to prevent disease progression, improve clinical conditions, and protect against long-term health complications.


Whether you’re interested in quality, safety, or specific ingredients, we’re here to answer your questions.

Shopping Cart